Leica Biosystems is recalling 98 units of the HistoCore PEGASUS and HistoCore PEGASUS Plus automated tissue processors because of a software-related processing issue. An incorrect assignment of carryover values in created or edited protocols can result in poorly processed or damaged biopsy tissue specimens. These devices were distributed nationwide in the United States and are manufactured in Germany. Because these devices are used to process patient tissue samples for diagnostic purposes, damaged specimens could lead to delayed or incorrect diagnoses.
The defect involves an error in how the system calculates chemical carryover between processing steps, which can degrade or damage delicate patient tissue samples during laboratory processing. If tissue is damaged beyond repair, it may be impossible to perform necessary medical testing, potentially requiring patients to undergo repeat biopsies or resulting in diagnostic errors.
Technical correction of protocol settings
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.